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Non-muscle (NM) myosin heavy chain phosphorylation
regulates the formation of NM myosin filaments,
adhesome assembly and smooth muscle contraction
Wenwu Zhang and Susan J. Gunst
Department of Cellular & Integrative Physiology, Indiana University School of Medicine, Indianapolis, IN, USA
Key points
 Non-muscle (NM) and smooth muscle (SM) myosin II are both expressed in smooth muscle
tissues, however the role of NMmyosin in SM contraction is unknown.
 Contractile stimulation of tracheal smooth muscle tissues stimulates phosphorylation of the
NM myosin heavy chain on Ser1943 and causes NM myosin filament assembly at the SM cell
cortex.
 Expression of a non-phosphorylatable NMmyosin mutant, NMmyosin S1943A, in SM tissues
inhibits ACh-induced NM myosin filament assembly and SM contraction, and also inhibits
the assembly of membrane adhesome complexes during contractile stimulation.
 NM myosin regulatory light chain (RLC) phosphorylation but not SM myosin RLC
phosphorylation is regulated by RhoA GTPase during ACh stimulation, and NM RLC
phosphorylation is required for NMmyosin filament assembly and SM contraction.
 NM myosin II plays a critical role in airway SM contraction that is independent and distinct
from the function of SM myosin.
Abstract The molecular function of non-muscle (NM) isoforms of myosin II in smooth muscle
(SM) tissues and their possible role in contraction are largely unknown.We evaluated the function
of NM myosin during contractile stimulation of canine tracheal SM tissues. Stimulation with
ACh causedNMmyosin filament assembly, as assessed by a Triton solubility assay and a proximity
ligation assay aiming to measure interactions between NM myosin monomers. ACh stimulated
the phosphorylation of NM myosin heavy chain on Ser1943 in tracheal SM tissues, which can
regulate NM myosin IIA filament assembly in vitro. Expression of the non-phosphorylatable
mutant NM myosin S1943A in SM tissues inhibited ACh-induced endogenous NM myosin
Ser1943 phosphorylation, NMmyosin filament formation, the assembly of membrane adhesome
complexes and tension development. The NMmyosin cross-bridge cycling inhibitor blebbistatin
suppressed adhesome complex assembly and SM contraction without inhibiting NM myo-
sin Ser1943 phosphorylation or NM myosin filament assembly. RhoA inactivation selectively
inhibited phosphorylation of the NMmyosin regulatory light chain (RLC), NMmyosin filament
assembly and contraction, although it did not inhibit SMRLCphosphorylation.We conclude that
the assembly and activation of NMmyosin II is regulated during contractile stimulation of airway
SM tissues by RhoA-mediated NMmyosin RLC phosphorylation and by NMmyosin heavy chain
Ser1943 phosphorylation. NMmyosin II actomyosin cross-bridge cycling regulates the assembly
of membrane adhesome complexes that mediate the cytoskeletal processes required for tension
generation. NM myosin II plays a critical role in airway SM contraction that is independent and
distinct from the function of SM myosin.
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Introduction
Non-muscle (NM) myosin II is ubiquitously expressed
in all cell types and constitutes the primary motor for
motility, migration and adhesion in non-muscle cells.
Although non-muscle isoforms of myosin II are also
expressed in muscle tissues, muscle-specific isoforms of
myosin II provide the molecular motors for mechanical
force generation and contraction. The contractile
stimulation of smooth muscle cells activates actomyosin
cross-bridge cycling by regulating phosphorylation of the
20 kDa regulatory light chain (RLC) of smooth muscle
(SM)myosin. Although there is some evidence suggesting
that NM myosin II can be regulated during smooth
muscle contraction and that it also contributes to tension
generation (Morano et al. 2000; Lofgren et al. 2003; Yuen
et al. 2009), such evidence is controversial, and some
investigators have concluded that NM myosin II plays no
role in smooth muscle contraction (Eddinger & Meer,
2007). Consequently, the molecular function of NMmyo-
sin II in smooth muscle tissues and the nature of its role
in contraction is unclear.
All isoforms of myosin II have a similar structure
consisting of three pairs of peptides: two 230 kDa heavy
chains with an α-helical coiled-coil rod backbone and a
short non-helical tail; two globular head domains that
contain the ATP and actin binding sites; two 20 kDa RLCs
that regulate the ATPase activity of the globular heads;
and two essential light chains that stabilize the heavy chain
structure (Vicente-Manzanares et al. 2009). Non-muscle
and smooth muscle isoforms of myosin II exhibit a high
degree of sequence similarity and are both regulated by
phosphorylation of the 20 kDa RLC, which activates
actomyosin cross-bridge cycling (Bresnick, 1999; Eddinger
& Meer, 2007; Yuen et al. 2009; Heissler & Sellers, 2016).
Both SM and NMmyosin II isoforms also contain a short
non-helical C-terminal tailpiece that regulates filament
assembly, which is variable in length and isoform-specific.
SM and NM myosin II monomers in vitro can assume
a folded inactive ‘assembly-incompetent’ conformation
(10S form) that is unable to assemble into filaments,
and an open ‘assembly-competent’ conformation (6S
form) (Scholey et al. 1980; Trybus & Lowey, 1984;
Vicente-Manzanares et al. 2009; Dulyaninova & Bresnick,
2013; Heissler & Sellers, 2016). The folded inactive ‘10S’
myosin II interactsweaklywith actin anddoesnot compete
with filamentous myosin for actin binding (Wendt et al.
1999; Jung et al. 2008). The phosphorylation of the 20 kDa
RLC of SM andNMmyosin II in vitro causes 10S (inactive
folded) myosin II to unfold into its assembly-competent
(6S) conformation that can form filaments (Scholey
et al. 1980; Smith et al. 1983; Trybus & Lowey, 1984;
Vicente-Manzanares et al. 2009; Dulyaninova & Bresnick,
2013). The regulated interconversion ofmyosin II between
a folded inactive conformer and an assembly-competent
conformation has been documented in vitro but not
in vivo (Trybus&Lowey, 1984;Kendrick-Jones et al. 1987).
There is evidence from several non-muscle cell lines that
a pool of NM myosin II in the assembly-incompetent
auto-inhibited state is necessary forNMmyosin II filament
assembly and cell migration (Breckenridge et al. 2009;
Kiboku et al. 2013). The existence of a pool of SM myo-
sin in the 10S assembly-incompetent conformation has
been documented in cultured airway smooth muscle cells
(Milton et al. 2011). However, in an earlier study of
chicken gizzard tissue, only trace amounts of 10S myo-
sin II could be detected using an antibody specific for
the 10S conformation (Horowitz et al. 1994). There is no
evidence as to whether NM myosin II filament assembly
is regulated in muscle tissues.
Sequences within the myosin II heavy chain near the
C-terminal of the α-helical coiled-coil rod domain and
the C terminal tailpiece are critical for the assembly of
myosin II monomers into filaments (Ronen & Ravid,
2009; Dulyaninova&Bresnick, 2013;Heissler &Manstein,
2013; Beach & Hammer, 2015). In vitro protein assays
using C terminal fragments of NM myosin IIA heavy
chain have suggested that phosphorylation at Ser1943
within its tailpiece is associated with a reduction in
NM myosin IIA filament assembly (Dulyaninova et al.
2005, 2007; Dulyaninova & Bresnick, 2013). Furthermore,
phosphorylation at Ser1943 inhibits cell migration and
motility and reduces lamellipodextension in vivo in several
cancer cell lines (Dulyaninova et al. 2007). However, it is
not known whether the phosphorylation of NM myosin
II heavy chain and/or NM myosin II filament assembly is
regulated in smooth muscle.
The contractile stimulation of airway smooth muscle
and other smooth muscle tissues induces the poly-
merization of a small pool of actin at the cortex of the
smooth muscle cell (Mehta & Gunst, 1999; Zhang et al.
2005; Gunst & Zhang, 2008; Kim et al. 2008; Zhang &
Gunst, 2008; Lehman & Morgan, 2012). This actin poly-
merization is required for tensiondevelopment in addition
to actomyosin cross-bridge cycling. In smooth muscle
tissues, actin polymerization is regulated by protein
complexes within integrin-associated adhesion junctions
(adhesome complexes) and is catalysed by distinct
signalling pathways that are activated independently
of SM myosin RLC phosphorylation and actomyosin
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cross-bridge cycling (Opazo Saez et al. 2004; Zhang et al.
2005, 2012;Gunst&Zhang, 2008).Contractile stimulation
triggers the recruitmentofproteins tomembraneadhesion
junctions, where they assemble into adhesome signalling
complexes that regulate signalling pathways to mediate
actin polymerization and other cytoskeletal processes
necessary for tension generation (Zhang & Gunst, 2008;
Huang et al. 2011, 2014; Zhang et al. 2012, 2016; Wu
& Gunst, 2015; Wu et al. 2016). Non-muscle myosin II
plays an integral role in the processes of cell adhesion
and migration in non-muscle cells, and it is indispensable
for the assembly and disassembly of adhesions within
the lamellipodium (Vicente-Manzanares et al. 2009).
We hypothesized that NM myosin II might regulate
contraction in smooth muscle tissues by mediating
the assembly of adhesome complexes in response to
contractile stimuli.
In the present study, we aimed to determine whether
NM myosin II activation is necessary for tension
generation and also whether the assembly of NM myo-
sin II is regulated during smooth muscle contraction.
Accordingly, we investigated the role of NM myosin
II heavy chain phosphorylation on Ser1943, which has
been implicated in the regulation of NM myosin II
filament assembly in non-muscle cells. We also selectively
inhibited the phosphorylation of the 20 kDa NM myo-
sin II RLC during contractile stimulation to evaluate its
effect on NM myosin filament assembly and function.
Blebbistatin, a selective inhibitor of NM myosin, was
used to determine the effects of inhibiting NM myosin
cross-bridge cycling. The results obtained demonstrate
that the assembly andactivationofNMmyosin II is physio-
logically regulated during the contractile stimulation of
smooth muscle tissues and that it requires NM myosin
II heavy chain phosphorylation at Ser1943, as well as
RhoA-mediated NM myosin RLC phosphorylation. The
results of the present study further demonstrate that NM
myosin II regulates the assembly of adhesome complexes
during smooth muscle contraction that mediate cyto-
skeletal processes required for tension generation. We
conclude that NMmyosin II plays a critical role in smooth
muscle contraction that is independent and distinct from
the function of smooth muscle myosin II.
Methods
Ethical approval
All procedures were conducted in accordance with
procedures approved by the Institutional Animal Care
and Use Committee (IACUC) of Indiana University
School ofMedicine under theNational Research Council’s
Guide for the Care and Use of Laboratory Animals.
The Indiana University Laboratory Animal Resource
Center (LARC) at Indiana University School of Medicine
procured mongrel dogs (20–25 kg, either sex) from
LBL Kennels (Reelsville, IN, USA). LARC personnel
euthanized animals by I.V. injection of Fatal-Plus (Vortech
Pharmaceuticals, Ltd, Dearborn,MI, USA) (pentobarbital
sodium 390 mg ml−1; propylene glycol, 0.01 mg ml−1;
ethyl alcohol; 0.29mgml−1; benzyl alcohol (preservative),
0.2mgml−1) at a dose of0.3ml kg−1, in accordancewith
procedures approved by the IACUC of Indiana University
School of Medicine. After euthanization, a tracheal
segment was immediately removed and placed in physio-
logical saline solution (PSS). All investigators understand
the ethical principles underwhich the Journal of Physiology
operates and all work complies with these principles.
Preparation of smooth muscle tissues
and measurement of force
A tracheal segment was immediately removed and
immersed in PSS comprising (in mM): 110 NaCl, 3.4 KCl,
2.4 CaCl2, 0.8 MgSO4, 25.8 NaHCO3, 1.2 KH2PO4 and
5.6 glucose). Strips of tracheal smooth muscle (1.0 × 0.2
to 0.5 × 15 mm) were dissected free of connective and
epithelial tissues and maintained within a tissue bath in
PSS at 37°C. Force wasmeasured during isometric contra-
ctions by attaching the tissues to Grass force-displacement
transducers. Prior to the beginning of each experimental
protocol, muscle length was increased to maintain a pre-
load of0.5–1.0 g and tissues were stimulated repeatedly
with 10−5 MAChuntil stable responses were obtained. The
force of contraction in response to ACh was determined
before and after treatmentwith plasmids or other reagents.
Immunoblots
For biochemical analysis, muscle tissues were rapidly
frozen using liquid N2-cooled tongs and pulverized
in liquid N2 using a mortar and pestle. Pulverized
muscle strips were mixed with extraction buffer
containing: 20 mM Tris-HCl at pH 7.4, 2% Triton
X-100, 0.4% SDS, 2 mM EDTA, phosphatase inhibitors
(2 mM sodium orthovanadate, 2 mM molybdate and
2 mM sodium pyrophosphate) and protease inhibitors
(2 mM benzamidine, 0.5 mM aprotinin and 1 mM
phenylmethylsulphonyl fluoride). Each sample was
centrifuged and the supernatant was then boiled in sample
buffer (1.5% dithiothreitol, 2% SDS, 80 mM Tris-HCl,
pH 6.8, 10% glycerol and 0.01% bromphenol blue) for
5 min. Proteins were separated by SDS-PAGE and trans-
ferred to nitrocellulose. The nitrocellulose membrane was
blocked with 2–5% milk or Odyssey (Li-Cor Biosciences,
Lincoln, NE, USA) blocking buffer for 1 h and probed
with primary antibodies against proteins of interest over-
night followed by secondary antibodies for 1 h. Proteins
were visualized by enhanced chemiluminescence using a
ChemiDoc XRS detection system (Bio-Rad, Hercules, CA,
C© 2017 The Authors. The Journal of Physiology C© 2017 The Physiological Society
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USA) or by infrared fluorescence using anOdyssey imager
(Li-Cor Biosciences).
Transfection of smooth muscle tissues
Plasmids were introduced into tracheal smooth muscle
strips by the method of reversible permeabilization (Tang
et al. 2003; Zhang et al. 2005, 2010, 2012). Tissues were
equilibrated and the muscle length for the generation
of maximal isometric force was determined. Muscle
strips were then attached to metal mounts to maintain
them at constant length. The strips were incubated
successively in each of the following solutions: Solution
1 (at 4°C for 120 min) containing (in mM): 10 EGTA, 5
Na2ATP, 120 KCl, 2 MgCl2 and 20N-tris (hydroxymethyl)
methyl-2-aminoethanesulphonic acid (TES); Solution 2
(at 4°C overnight) containing (in mM): 0.1 EGTA, 5
Na2ATP, 120 KCl, 2 MgCl2, 20 TES and 20 μg ml−1
plasmids. Solution 3 (at 4°C for 30 min) containing (in
mM): 0.1 EGTA, 5 Na2ATP, 120 KCl, 10 MgCl2 and 20
TES; and Solution 4 (at 22°C for 90 min) containing (in
mM): 110 NaCl, 3.4 KCl, 0.8MgSO4, 25.8 NaHCO3, 1.2
KH2PO4 and 5.6 dextrose. Solutions 1–3 were maintained
at pH 7.1 and aerated with 100% O2. Solution 4 was
maintained at pH 7.4 and was aerated with 95% O2/5%
CO2. After 30 min in Solution 4, CaCl2 was added
gradually to reach a final concentration of 2.4 mM. The
strips were then incubated in a CO2 incubator at 37°C
for 2 days in serum-free Dulbecco’s modified Eagle’s
medium containing 5 mM Na2ATP, 100 Uml−1 penicillin,
100 μg ml−1 streptomycin, 50 μg ml−1 kanamycin,
2.5μg ml−1 anti-fungal and 20μg ml−1 plasmids to allow
for expression of the recombinant proteins. Expression of
recombinant proteins in transfected muscle tissues was
determined by immunoblots and immunofluorescence.
Cell dissociation
Freshly dissociated primary cells were used for these
studies to avoid the morphological changes in cytoskeletal
organization and changes in phenotype that occur during
the culture of smooth muscle cells. Smooth muscle cells
were enzymatically dissociated from trachealmuscle strips
(Opazo Saez et al. 2004; Zhang et al. 2005). Tracheal
muscle strips were minced and transferred to 5 ml of
dissociation solution (in mM): 130 NaCl, 5 KCl, 1.0 CaCl2,
1.0 MgCl2, 10 Hepes, 0.25 EDTA, 10 D-glucose and 10
taurine (pH 7.0) with collagenase (type IV, 400 U ml−1),
papain (type IV, 30 U ml−1), bovine serum albumin
(1 mgml−1) and dithiothreitol (DTT; 1 mM). All enzymes
were obtained from Sigma (St Louis, MO, USA). The
strips were then placed in a 37°C shaking water bath at
60 oscillations min−1 for 15–20 min, followed by three
washes with a Hepes-buffered saline solution (in mM):
130 NaCl, 5 KCl, 1.0 CaCl2, 1.0 MgCl2, 20 Hepes and
10 D-glucose (pH 7.4) and triturated with a pipette to
liberate individual smooth muscle cells from the tissue.
The solution containing the dissociated cells was poured
over glass coverslips and the cells were allowed to adhere
to the coverslips for 30–60 min at room temperature.
Cells were stimulated with 10−5 M ACh for 5 min at
37°Cor left unstimulated and used as controls. Stimulated
and unstimulated cells were fixed for 10 min in 4%
paraformaldehyde (v/v) in PBS (in mM): 137 NaCl, 4.3
Na2HPO4, 1.4 KH2PO4 and 2.7 KCl (pH 7.4).
In situ proximity ligation assay
In situ proximity ligation assays (PLA) were performed
as described previously to detect protein interactions
(Huang et al. 2011; Zhang et al. 2012, 2016). PLA provides
for the precise detection of protein–protein complexes
(Soderberg et al. 2006, 2008). Target proteins are reacted
with primary antibodies raised in different species, and
a pair of oligonucleotide-labelled secondary antibodies
conjugated to + and − PLA probes is targeted to each
pair of primary antibodies. The probes form circular
DNA strands only when they are bound in very close
proximity (<40nm).TheseDNAcircles serve as templates
for localized rolling circle amplification, generating a
fluorescence signal (spot) that enables individual inter-
acting pairs of the target protein molecules to be
visualized. The PLA signal allows for the detection of
a complex between two target proteins at a very high
resolution.
Smooth muscle cells were dissociated from Sham-
treated or transfected canine tracheal smooth muscle
tissues. Freshly dissociated smooth muscle cells were
stimulated with 10−5 M ACh or left unstimulated and
then fixed, permeabilized and incubated with primary
antibodies against target proteins or epitopes followed
by a pair of oligonucleotide-labelled secondary anti-
bodies conjugated to Duolink + and − PLA probes.
PLA probe hybridization, ligation, amplification and
detectionmedia were administered in accordance with the
manufacturer’s instructions (Olink Bioscience, Uppsala,
Sweden). Randomly selected cells from both unstimulated
and ACh-stimulated groups were analysed for protein
interactions by visualizing PLA fluorescence spots using
a LSM 510 confocal microscope (Carl Zeiss, Oberkochen,
Germany).
The total number of PLA fluorescence spots/cell
was counted using Image Tools (Olink Bioscience). In
some experiments, the distribution of PLA fluorescence
spots within each cell was quantified by separating
the region of the cell cortex from the cytoplasm by
a line 1 μm inside the cell border. The ratio of
fluorescence intensity between the cortical compartment
and the cytoplasmic compartment was calculated using
Metamorph (Molecular Devices, Inc. Sunnyvale, CA,
C© 2017 The Authors. The Journal of Physiology C© 2017 The Physiological Society
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USA) as described previously (Zhang et al. 2012). The
ratio of the area of cortical compartment to the area of
the cytoplasmic compartment did not differ significantly
in any of the groups.
Two-dimensional electrophoresis for the analysis
of NM and SM RLC phosphorylation
Canine tracheal smooth muscle tissues were stimulated
with 10 μM ACh or left unstimulated for 5 min
and frozen in liquid nitrogen. Frozen muscle strips
were immersed in dry ice-precooled acetone containing
10% (w/v) trichloroacetic acid and 10 mM DTT.
Proteins were extracted in 7 M urea, 2 M thiourea,
2% (w/v) 3-[(3-cholamidopropyl) dimethylammonio]-
1-propanesulphonate (CHAPS), 1% 3.9–5.1 immobilized
pH gradient (IPG) buffer and 1× Roche Complete
protease inhibitor. Suitable amounts of sample were
resolved in the first dimension using the acidic half of
11 cm (pH 3.9–5.1) IPG dry strip gels. After separation
in the first dimension, proteins were equilibrated in
6 M urea, 50 mM (pH 6.4) Bis-Tris, 30% (v/v)
glycerol, 2% SDS and 0.002% bromophenol blue, first
containing 10 mM DTT and then containing 2.5% (w/v)
iodoacetamide. Proteins were then separated in the second
dimension by SDS-PAGE electrophoresis, transferred to
nitrocellulose, and then immunoblotted for total RLC
and phospho-Ser19 RLC. Phosphorylation was calculated
from densitometry based on the intensity of the RLC
spots.
Mass spectrometry
Mass spectrometrywasused to identify themyosin SMand
NM RLC proteins separated by two-dimensional electro-
phoresis. The Indiana University School of Medicine
Proteomics Core Laboratory performed all procedures
for peptide identification. A database search for RLC
sequences was carried out using SequestTM algorithms
and the Canfa database (UniProt; www.uniprot.org).
There are four unique peptides in which amino acid
sequences differ between SM and NM myosin RLCs
(Park et al. 2011). We used the unique peptides
NAFACFDEEATGTIQEDYLR (NM myosin RLC) and
NAFACFDEEASGFIHEDHLR (SM myosin RLC) to
distinguishNM and SMmyosin RLC isoforms. Briefly, the
two-dimensional gel spots were destained, reduced with
10 mM DTT in 10 mM ammonium bicarbonate and then
alkylated with 55 mM iodoacetamide (prepared in 10 mM
ammoniumbicarbonate).Alkylated samplesweredigested
with trypsin (Promega, Madison, WI, USA) overnight at
37°C. Digested peptides were extracted from the gel spots.
Tryptic peptides were injected onto aMichromMagic C18
packed tip capillary column (Michrom BioResources Inc.,
Auburn, CA, USA). Peptides were eluted with a linear
gradient from 5% to 35% acetonitrile and developed over
60 min at room temperature, at a flow rate of 50 ul min−1,
after which effluent was electrosprayed into the LTQmass
spectrometer (Thermo Fisher Scientific Inc., Waltham,
MA, USA). Blanks were run prior to the sample run to
ensure there was no significant signal from solvents or the
column.
Triton solubility assay
A Triton solubility assay was performed on extracts
of smooth muscle tissues to separate cytoskeletal and
Triton-soluble proteins (Dulyaninova et al. 2007; Li et al.
2010; Kiboku et al. 2013). In brief, frozen and pulverized
tracheal smooth muscle tissue samples were mixed with
Triton X-100 lysis buffer (150 mM KCl, 20 mM Pipes,
10 mM imidazole, pH 7.0, 0.05% Triton X-100, 1 mM
MgCl2, 1 mM EGTA, 1 mM DTT, 0.1 mM phenylmethane
sulphonyl fluoride, 5 μg ml−1 aprotinin, 5 μg mL−1
leupeptin, 2 μg mL−1 pepstatin A, 1 mM Na3VO4 and
20mMβ-glycerophosphate) at 4°C.After 5min, the lysates
were centrifuged at 8000 g for 5min at 4°C, and the super-
natant was removed as the soluble fraction. The pellet, the
insoluble fraction, was added to equal volumes of Triton
X-100 lysis buffer with an additional 0.8% SDS and 2 mM
EDTA, boiled for 5 min and rotated for 1 h, and then
centrifuged at 16,000 g for 15 min at 4°C. The super-
natant was transferred to another tube as the insoluble
fraction. Equal volumes of soluble and insoluble fractions
from the same sample were used for immunoblots.
Analysis of F-actin and G-actin
The relative proportions of F-actin and G-actin in
smooth muscle tissues were analysed as described pre-
viously (Zhang et al. 2005, 2010). Briefly, each of the
tracheal smooth muscle strips was homogenized in
200 μl of F-actin stabilization buffer (50 mM PIPES,
pH 6.9, 50 mM NaCl, 5 mM MgCl2, 5 mM EGTA, 5%
glycerol, 0.1% Triton X-100, 0.1% Nonidet P-40, 0.1%
Tween-20,0.1% β-mercaptoethanol, 0.001% anti-foam,
1 mM ATP, 1 μg ml−1 pepstatin, 1 μg ml−1 leupeptin,
10 μg ml−1 benzamidine and 500 μg ml−1 tosyl
arginine methyl ester). Supernatants of the protein
extracts were collected after centrifugation (OptimaMAX
Ultracentrifuge; BeckmanCoulter, Fullerton, CA, USA) at
150,000 g for 60min at 37°C.The pellets were resuspended
in 200 μl of ice-cold water containing 10 μM cytochalasin
D and then incubated on ice for 1 h to depolymerize
F-actin. The resuspended pellets were mixed gently every
15 min. Four microlitres of supernatant (G-actin) and
pellet (F-actin) fractions were subjected to immunoblot
analysis using anti-actinantibody (clone AC-40; Sigma).
The ratios of F-actin to G-actin were determined using
densitometry.
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Reagents and antibodies
Sources of antibodies were: polyclonal rabbit anti-human
phospho-myosin IIA (Ser1943) (catalogue number
5026; Cell Signaling Technology, Beverly, MA, USA);
monoclonal mouse anti-human non-muscle myosin
IIA (catalogue number ab55456; Abcam, Cambridge,
MA, USA); monoclonal mouse anti-human non-muscle
myosin IIB (catalogue number ab684; Abcam); poly-
clonal rabbit anti-human non-muscle myosin IIA
(catalogue number M8064; Sigma); polyclonal rabbit
anti-human non-muscle myosin IIB (catalogue number
M7939; Sigma); monoclonal mouse anti-human
paxillin (catalogue number 610569; BD Transduction,
Lexington, KT, USA); polyclonal rabbit anti-human
paxillin phospho-tyrosine 118 (catalogue number
44-722G; Invitrogen, Carlsbad, CA, USA); horse-
radish peroxidase-conjugated IgG (catalogue number
NA931 & NA934; Amersham Biosciences, Piscataway,
NJ, USA); IRDye R© 680RD Donkey-anti-Mouse IgG
(catalogue number 926-68070) and IRDye R© 800CW
Donkey-anti-Rabbit IgG (catalogue number 925-32211;
Li-Cor Biosciences); polyclonal rabbit anti-canine cardiac
vinculin and polyclonal rabbit anti-bovine smooth
muscle myosin regulatory light chain were custom
made by BABCO (Richmond, CA, USA). Odyssey R©
blocking buffer (catalogue number 927-50000) was
obtained from Li-Cor Biosciences. All antibodies
have been validated to confirm their reaction with
the designated antigen in the smooth muscle tissue
extracts, immunoblots or fixed cells. The Duolink
in situ PLA (Olink Bioscience) was obtained from Sigma
Chemical Co. Blebbistatin was also obtained from Sigma
Chemical Co.
Plasmids encoding wild-type and the Ser1943 point
mutant of NM myosin heavy chain (pEGFP-NMHC-IIA
and pEGFP-NMHC-IIA-S1943A) (Dulyaninova et al.
2007) were generously provided by Dr Anne R. Bresnick
(Albert Einstein College of Medicine, Bronx, New York,
NY,USA). pEGFP-NMHC-IIA-WTwas generated by sub-
cloning a DNA fragment encoding residues 1–1960 from
human NMmyosin-IIA heavy chain into the HindIII and
SalI sites of pEGFP-C3 (Clontech, Palo Alto, CA, USA).
In pEGFP-NMHC-IIA-S1943A, Ser1943 was replaced by
alanine.
Plasmids encoding human RhoA T19N have been
described previously (Strassheim et al. 1999; Zhang et al.
2010). The cDNAs encoding theRhoAwithhemagglutinin
(HA)-RhoA Asn19 mutant were subcloned into the
mammalian expression vector pcDNA3.1.
Escherichia coli (Bluescript) transformed with these
plasmids was grown in LB medium, and plasmids were
purified by alkaline lysis with SDS using a purification kit
from Qiagen Inc. (Valencia, CA, USA).
Statistical analysis
Comparisons between two groups were performed
using a paired or unpaired two-tailed Student’s t test.
Comparisons among multiple groups were performed by
ANOVA. Values of ‘n’ refer to the number of cells or tissue
strips used to obtainmean values. P< 0.05was considered
statistically significant.
Results
Contractile stimulation induces NM myosin II
assembly in airway smooth muscle tissues
We evaluated the effect of stimulation with ACh on the
assembly status of NM myosin II in tracheal smooth
muscle tissues using a fractionation assay to quantify
the ratio of NM myosin in the cytoskeletal and Triton
X-soluble fractions of tissue extracts at time points
from 1 to 10 min after stimulation with 10−5 M ACh
(Fig. 1A) (Dulyaninova et al. 2005, 2007; Breckenridge
et al. 2009; Milton et al. 2011). The proportion of NM
myosin IIA and IIB isoforms in the cytoskeletal fraction
of smooth muscle tissue extracts increased significantly
within 1 min after stimulation with ACh, and rose
by three- to four-fold within 2 min with a time course
similar to tension development (Fig. 1B). These results
suggest that stimulation of airway smooth muscle tissues
with ACh triggers rapid NMmyosin actomyosin assembly
involving both A and B isoforms of NMmyosin II.
We also used in situ PLA analysis to assess interactions
between A and B isoforms of NMmyosin II as an index of
NM myosin II filament formation during the contractile
stimulation of freshly dissociated tracheal smooth muscle
cells. Because NM myosin II isoforms can coassemble
into heterotypic filaments (Beach et al. 2014; Beach &
Hammer, 2015), interactions between NM myosin IIA
and IIB isoforms were quantified to assess the formation
of NM myosin II polymers. We observed few interactions
between NM myosin IIA and IIB in unstimulated cells,
whereas the interaction of NM myosin IIA and IIB iso-
forms dramatically increased in cells stimulated with ACh
(Fig. 1C). Interactions between NM myosin IIA and IIB
were localized to the cortical region of the smooth muscle
cells (Fig. 1C). We also used PLA to probe for interactions
between NM myosin IIA and SM myosin to confirm
the specificity of the PLA assay for NM myosin II iso-
form interactions (Fig. 1D). As expected, no interactions
between NM myosin IIA and SM myosin were observed
in unstimulated or ACh-stimulated smooth muscle cells.
These results suggest that contractile stimulation triggers
the assembly ofNMmyosin II into filaments in the cortical
region of airway smooth muscle cells, and that these NM
myosin II filaments remain stable for the 10 min period of
contractile stimulation.
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Stimulation of tracheal smooth muscle tissues with
ACh induces phosphorylation of Ser1943 on the tail
domain of the NM myosin II heavy chain
We investigated the effect of stimulation with 10−5 M ACh
on the phosphorylation of Ser1943 within the non-helical
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Figure 1. Contractile stimulation induces the assembly of NM
myosin II filaments in airway smooth muscle tissues
tail domain of NM myosin II in tracheal muscle tissues
(Fig. 2A).Muscle tissueswere frozenat 1, 2 5or10minafter
stimulation with ACh, and the Ser1943 phosphorylation
of NM myosin II was probed in immunoblots using a
site-specific antibody (Fig. 2A). NM myosin II Ser1943
phosphorylation increased significantly within 1 min of
stimulation with ACh and continued to rise for the 10min
stimulation period. The time course of the increase in
NM myosin heavy chain phosphorylation was consistent
with that of force development and NM myosin filament
assembly.
We evaluated the cellular localization of Ser1943
phosphorylated NM myosin IIA using in situ PLA
in freshly dissociated differentiated tracheal smooth
muscle cells to determine interactions between the
phospho-Ser1943 epitope and NM myosin IIA.
We observed very few spots indicating Ser1943
phosphorylated NM myosin IIA in unstimulated
cells, consistent with our immunoblot data showing
little phosphorylation of NM myosin IIA Ser1943 in
unstimulated smooth muscle. Stimulation with ACh
caused a dramatic increase in the number of PLA
spots near the cell membrane, suggesting an increase of
NM myosin IIA Ser1943 phosphorylation in membrane
complexes.
We also probed for interactions between NM myosin
phospho-Ser1943 and NM myosin IIB. No interactions
were observed in unstimulated cells, although an increase
in PLA spotswas seen inACh-stimulated cells.NMmyosin
IIB has a serine phosphorylation site at residue 1952 that
may be analogous to that at Ser1943 in NM myosin IIA
(Dulyaninova & Bresnick, 2013); thus, these spots may be
indicative of NMmyosin IIB heavy chain phosphorylation
at that site. Alternatively, the spots may indicate
A, typical time course for force development during stimulation of
muscle tissues with 10−5 ACh, illustrating the points at which
muscle tissues were quick frozen for the Triton solubility assay
(upper). The ratio of NM myosin IIA and IIB isoforms in the Triton
X-insoluble cytoskeletal (P) fraction vs. soluble (S) fraction of tissue
extracts was assessed by immunoblot in five individual tracheal
smooth muscle tissues frozen 1, 2, 5 or 10 min after contractile
stimulation with ACh and unstimulated (US) (lower). B, P/S ratios of
both A and B isoforms of NM myosin II increased significantly after
ACh stimulation for 1 min or more relative to unstimulated tissues
(n = 9). C, in situ PLA was used to determine the interaction of NM
myosin IIA and NM myosin IIB in freshly dissociated differentiated
tracheal smooth muscle cells. PLA fluorescence alone and merged
with phase contrast images are shown for each cell. In US cells, very
few spots were observed. Stimulation with ACh caused a significant
increase in the number of PLA spots at the cell membrane (n = 17
cells). D, in situ PLA shows the interaction of NM myosin IIA and SM
myosin in freshly dissociated smooth muscle cells. Very few spots
were observed in either unstimulated or ACh stimulated cells
(n = 31 for US; n = 34 for ACh). All values are the mean ± SEM.
∗Significant difference compared to US (P < 0.05).
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interactions between Ser1943-phosphorylated NM myo-
sin IIA and NMmyosin IIB within heterotypic filaments.
Sequencing data for MYH11 have shown that the
Ser1943 consensus sequence is not present on the smooth
muscle isoform of myosin II (Eddinger &Meer, 2007) and
so a SMmyosin heavy chain specific antibody was used to
confirm that the NM myosin II Ser1943 antibody did not
react with SM myosin (Fig. 2B). We observed negligible
interactions between phospho-NM myosin IIA Ser1943
and SM myosin heavy chain in either unstimulated or
ACh-stimulated cells, confirming that the PLA assay is
specific for NMmyosin II phospho-Ser1943.
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Figure 2. Stimulation of tracheal smooth muscle tissues with ACh induces phosphorylation of Ser1943
on the NM myosin II heavy chain at the cell cortex
A, immunoblot of phospho (P)-NM myosin Ser1943 and NM myosin IIA from extracts of five muscle tissues
stimulated with ACh for 1, 2, 5 or 10 min or unstimulated (US). Proteins were imaged by dual fluorescence. The
ratio of phospho-Ser1943 to NM myosin IIA was determined for each sample and normalized to the value for
the US tissue. Non-muscle myosin II heavy chain Ser1943 phosphorylation increased significantly after 1, 2, 5 or
10 min ACh stimulation compared to unstimulated tissues (n = 12). B, images of in situ PLA fluorescence (top) and
PLA fluorescence merged with phase contrast (bottom) from freshly dissociated smooth muscle cells unstimulated
(US) or stimulated with ACh. PLA shows interactions between NM myosin IIA and phospho-NM myosin Ser1943
(left), NMmyosin IIB and phospho-NMmyosin Ser1943 (middle) and SMmyosin and phospho-NMmyosin Ser1943
(right). Very few interactions between NMmyosin IIA and phospho-NM myosin Ser1943 are observed in any of the
unstimulated cells. ACh stimulation caused a significant increase in the number of PLA spots at the cell cortex for
NM myosin IIA (n = 17, US; n = 28, ACh) and IIB (n = 16, US; n = 26, ACh) but did not result in any interactions
between SM myosin and phospho-NM myosin Ser1943 and NM myosin IIB (n = 13, US; n = 15, ACh). All values
are the mean ± SEM. ∗Significant difference compared to unstimulated tissues (P < 0.05).
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These results suggest that phosphorylated NM
myosin IIA localizes to the cortical region of
the smooth muscle cells and undergoes heavy
chain phosphorylation on Ser1943 during contractile
stimulation.
NM myosin II heavy chain Ser1943 phosphorylation
regulates NM myosin filament assembly and tension
development in smooth muscle tissues
We used a non-phosphorylatable mutant of the NM
myosin IIA isoform, EGFP-NM myosin IIA S1943A
(Dulyaninova et al. 2007) to determine whether
phosphorylation at this site regulates NM myosin II
assembly in smooth muscle tissues during contractile
stimulation. We transfected tracheal smooth muscle
tissues with pEGFP-NMHC IIA S1943A using themethod
of reversible permeabilization. Expression of the recom-
binant protein was confirmed by immunoblot and
also by visualizing enhanced green fluorescent protein
(EGFP) fluorescence in cells dissociated from the trans-
fected tissues (Fig. 3A). The increase in the Ser1943
phosphorylationof endogenousNMmyosin II in response
to 5 min of stimulation with ACh was significantly
inhibited in tissues expressing EGFP-NM myosin IIA
S1943A (Fig. 3A).
We evaluated the effect of inhibiting NM myosin
Ser1943 phosphorylation on the assembly of NM myo-
sin IIA in the tracheal smooth muscle tissues (Fig. 3B).
In tissues subjected to Sham transfections, the amount
of NM myosin IIA in the cytoskeletal fraction of tracheal
tissue extracts increased significantly in response to 5 min
of stimulation with ACh. The increase in NM myosin IIA
in the cytoskeletal fraction in ACh-stimulated tissues was
significantly inhibited by the expression of NM myosin
S1943A in the tissues. These observations suggest that
NM myosin Ser1943 phosphorylation is required for NM
myosin II actomyosin assembly in response to contractile
stimulation.
The role of NM myosin heavy chain Ser1943
phosphorylation on NM myosin II filament assembly
was also assessed by in situ PLA in freshly dissociated
tracheal smooth muscle cells (Fig. 3C). Smooth muscle
cells were dissociated from tissues expressing the NM
myosin S1943Amutant and from Sham-treated tissues. In
cells from Sham-treated tissues, ACh stimulation induced
interactions between NM myosin IIA and IIB isoforms
indicating NM myosin filament formation. By contrast,
few interactions between NM myosin IIA and IIB iso-
forms were observed in cells from tissues treated with the
NM myosin S1943A mutant. These observations provide
additional evidence that NM myosin II heavy chain
Ser1943 phosphorylation regulates NM myosin filament
formation and actomyosin assembly in smooth muscle
tissues stimulated by ACh.
In tissues expressing NMmyosin S1943A, the contract-
ile response to ACh was reduced to less than 40% of that
in Sham-treated tissues. Tissues expressing wild-type NM
myosin IIA or Sham-treated tissues exhibited no deficits
in force development in response to ACh (Fig. 3D). These
results suggest that NMmyosin II filament formation and
assembly contributes to contractile tension development
in airway smooth muscle tissues.
NM myosin II regulates the assembly and activation
of membrane adhesion junction signalling complexes
during the contractile stimulation of smooth muscle
tissues
We evaluated the role of NMmyosin II filament assembly
in the regulation of adhesion complex assembly and the
activationof adhesomeproteins in tracheal smoothmuscle
tissues during contractile stimulationwith ACh. Adhesion
junction proteins are recruited to integrin adhesomes
during the contractile stimulation of intact airway smooth
muscle tissues and differentiated freshly dissociated air-
way smooth muscle cells (Opazo Saez et al. 2004; Zhang
& Gunst, 2008; Zhang et al. 2012, 2016). The assembly
of these adhesome complexes is required for tension
development in response to the contractile stimulation
of airway smooth muscle.
The activation of tracheal smooth muscle tissues with a
contractile agonist stimulates the recruitment of vinculin
to adhesome complexes, where vinculin undergoes a
conformational change that permits its binding to talin
and F-actin (Huang et al. 2011; Huang et al. 2014). We
performed in situ PLA on smooth muscle cells freshly
dissociated from tissues expressing NMmyosin II S1943A
to evaluate the role of NM myosin IIA in the recruitment
of vinculin to adhesomes and its interaction with talin
at the membrane (Fig. 4A). In cells from Sham-treated
tissues, stimulation with ACh caused a dramatic increase
in the interaction of vinculin and talin at cell adhesion
junction sites, as indicated by a large increase in the
number of PLA fluorescence spots at the cell membrane.
The ACh-induced increase in the interactions between
vinculin and talin was completely inhibited in cells from
tissues expressingNMmyosin S1943A, indicating thatNM
myosin IIA filament assembly regulates the recruitment of
vinculin to the cell cortex and/or its interaction with talin
in adhesome complexes.
Vinculin forms a stable complex with paxillin that
is maintained in both unstimulated and stimulated air-
way smooth muscle tissues (Opazo Saez et al. 2004;
Huang et al. 2011; Zhang et al. 2012). The stimulation
of tracheal smooth muscle tissues with ACh results
in the recruitment of paxillin/vinculin complexes to
membrane adhesion complexes (Zhang et al. 2012). We
used PLA to determine the role of NM myosin II on the
recruitment of paxillin/vinculin complexes to membrane
C© 2017 The Authors. The Journal of Physiology C© 2017 The Physiological Society
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Figure 3. NM myosin II heavy chain Ser1943 phosphorylation regulates NM myosin filament assembly
and tension development in smooth muscle tissues
A, EGFP fluorescence was observed in most cells dissociated from tissues expressing the non-phosphorylatable NM
myosin IIA mutant, EGFP-NM IIA-S1943A. The increase in NM myosin II Ser1943 phosphorylation in response to
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5min of stimulation with 10−5 M ACh was significantly inhibited in tissues expressing NMmyosin S1943A (n = 18).
B, ratio of NM myosin II in the cytoskeletal (P) vs. soluble (S) fractions increased in response to 5 min of stimulation
with 10−5 M ACh in Sham-treated tissues but was significantly inhibited by the expression of NM myosin II
Ser1943A in ACh-stimulated tissues (n = 8). C, in situ PLA fluorescence (top) and PLA fluorescence merged with
phase contrast (bottom) from freshly dissociated smooth muscle cells unstimulated (US) or stimulated with ACh.
PLA spots show interactions between NM myosin IIA and NM myosin IIB in cells dissociated from Sham-treated
tissues (left), and in cells dissociated from tissues expressing EGFP-NM myosin IIA-S1943A (right). ACh stimulation
of Sham-treated tissues resulted in a significant increase in the number of NM myosin IIA and IIB complexes at
the cell cortex (n = 27, US; n = 30 ACh). By contrast, few NM myosin IIA and IIB complexes were observed in
cells from tissues treated with the NM myosin S1943A (US, n = 27; ACh, n = 30). Very few NM myosin IIA and
IIB complexes are observed in the unstimulated cells. D, contractile force in response to ACh is shown for tissues
before and after they were transfected with plasmids encoding wild type (WT) EGFP-NM myosin IIA heavy chain,
EGFP-NMmyosin IIA S1943A or no plasmids (Sham) (n= 10). All force measurements were normalized to the Sham
response. The expression of NM myosin S1943A mutant significantly inhibited tension development in response
to 10−5 M ACh stimulation. All values are the mean ± SEM. ∗Significant difference between treatment groups
(P < 0.05).
adhesion junctions in response to ACh (Fig. 4B). In
Sham-treated tissues, paxillin/vinculin complexes were
observed throughout the cytoplasm of unstimulated cells,
whereas, after contractile stimulation, they were localized
predominantly within the submembranous cortex of
ACh-stimulated cells. In cells expressing NM myo-
sin IIA S1943A, paxillin/vinculin complexes did not
localize to the cortex of ACh-stimulated cells; a diffuse
distribution throughout the cytoplasm was observed in
bothACh-stimulated andunstimulated cells. These results
suggest that NM myosin II assembly is necessary for the
recruitment of paxillin/vinculin complexes to membrane
adhesomes in response to stimulation with ACh. We
conclude that NMmyosin II regulates adhesome complex
assembly during the contractile activation of smooth
muscle.
Vinculin and paxillin are activated by tyrosine
phosphorylation within membrane adhesion complexes
in airway smooth muscle tissues, and their activation
regulates thedownstreamsignallingpathways thatmediate
actin polymerization and contraction (Tang et al. 2003;
Huang et al. 2011; Zhang et al. 2012, 2016; Wu &
Gunst, 2015). Vinculin phosphorylation on Tyr1065 at
its C-terminus regulates a conformational change that
enables it to bind to F-actin and talin (Huang et al. 2014),
whereas paxillin phosphorylation at Tyr31 and Tyr118
regulates its coupling to signalling complexes that catalyse
actin polymerization (Tang et al. 2005; Zhang et al. 2016).
We analysed the effect of expressing NM myosin S1943A
on the tyrosine phosphorylation of both paxillin and
vinculin in response to contractile stimulation with ACh
(Fig. 4C). Vinculin Tyr1065 phosphorylation and paxillin
Tyr118 phosphorylation in response to ACh stimulation
were both inhibited by expression of the NM myosin
S1943A mutant.
Contractile stimulation of airway smoothmuscle elicits
the polymerization of a small pool of actin, and this
actin polymerization is required in addition to SM myo-
sin RLC phosphorylation and cross-bridge cycling for
the development of active tension in airway smooth
muscle (Gunst & Zhang, 2008; Zhang et al. 2015). The
signalling proteins that catalyse the polymerization of
actin during contractile activation localize to adhesion
junction complexes (Zhang et al. 2005, 2012, 2015; Wu
& Gunst, 2015). We therefore evaluated the role of NM
myosin II Ser1943 phosphorylation and NM myosin II
assembly in ACh-stimulated actin polymerization.
Actin polymerization was measured in canine tracheal
smooth muscle tissues using a fractionation assay to
separate soluble (G-actin) and insoluble (F-actin) actin
in the muscle extracts (Tang et al. 2005; Zhang et al.
2005, 2010, 2016). The expression of NM myosin II
S1943A in the tissues significantly inhibited the increase
in actin polymerization (increase in F-actin/G-actin ratio)
in response to stimulation with ACh (Fig. 4D). The results
suggest that the NMmyosin II assembly regulates cortical
actin polymerization in response to a contractile stimulus
by regulating the assembly of adhesome signalling
complexes.
Actomyosin cross-bridge cycling by NM myosin II is
required for the assembly and activation of
membrane adhesome signalling complexes and
tension development during the contractile
stimulation of tracheal smooth muscle tissues
We evaluated the role of cross-bridge cycling by NM
myosin II on tension development, NM myosin II
filament formation, and adhesome protein recruitment
and activation in tracheal smooth muscle tissues by
treating tissues with blebbistatin. Blebbistatin prevents
cross-bridge cycling by non-muscle myosin II by binding
to its head domain and blocking it in an actin-detached
state. Although blebbistatin is a potent and selective
inhibitor of actomyosin cross-bridge cycling by NMmyo-
sin II isoforms, it does not inhibit cross-bridge cycling by
smoothmusclemyosin II (Straight et al. 2003; Kovacs et al.
2004).
Tracheal smooth muscle tissues were incubated in
10 μM blebbistatin for 30 min and then contracted with
C© 2017 The Authors. The Journal of Physiology C© 2017 The Physiological Society
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Figure 4. NM myosin II Ser1943 phosphorylation regulates the assembly and activation of membrane
adhesion junction signalling complexes and actin polymerization
A and B, images of in situ PLA fluorescence (top) and PLA fluorescence merged with phase contrast (bottom)
from freshly dissociated smooth muscle cells unstimulated (US) or stimulated with ACh. A, PLA shows inter-
actions between vinculin and talin in cells dissociated from Sham-treated tissues (left), and in cells dissociated
from tissues expressing EGFP-NM myosin IIA-S1943A (right). ACh stimulation of Sham-treated tissues resulted
in a significant increase in the number of PLA spots at the cell cortex indicating interactions between vinculin
and talin (n = 26, US; n = 29, ACh). By contrast, few spots were observed in cells from tissues treated with the
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NM myosin S1943A (US, n = 17; ACh, n = 25). Very few spots are observed in the unstimulated cells. B, PLA
shows interactions between vinculin and paxillin in cells dissociated from Sham-treated tissues (left), and in cells
dissociated from tissues expressing EGFP-NM myosin IIA-S1943A (right). Paxillin/vinculin complexes are distributed
throughout the cytoplasm of unstimulated cells from both Sham-treated and EGFP-NMmyosin IIA-S1943A treated
tissues. ACh stimulation resulted the localization of paxillin/vinculin complexes to the cell cortex of Sham-treated
cells, although paxillin/vinculin complexes remained distributed throughout the cytoplasm of EGFP-NM myosin
IIA-S1943A treated cells. The ratio of the cellular distribution of paxillin/vinculin complexes between the cortex
and the cytoplasm was quantified for each cell. The ratio of the distribution of paxillin/vinculin complexes between
the cortex/cytoplasm was significantly higher for Sham-treated cells than for EGFP-NM myosin IIA-S1943A-treated
cells after ACh stimulation (n = 16 from each group). C, representative immunoblot from extracts of four muscle
tissues treated with NM myosin S1943A or Sham-treated and then stimulated with ACh or not stimulated (US)
(left). Vinculin Tyr1065 phosphorylation and paxillin Tyr118 phosphorylation increased significantly in response
to 10−5 M ACh in Sham treated tissues. Expression of NM myosin S1943A mutant inhibited the ACh-induced
increase in both vinculin Tyr 1065 phosphorylation (n = 13) and paxillin Tyr 118 phosphorylation (n = 10).
D, immunoblot of soluble G-actin (globular) and insoluble F-actin (filamentous) in fractions from extracts
of US or ACh stimulated muscle tissues treated with NM myosin S1943A mutant or Sham-treated. Ratios
of F-actin to G-actin were determined by quantitating F and G actin in extracts from each muscle strip
(left). Expression of NM myosin S1943A prevented the increase in F-actin/G-actin ratio in response to
ACh stimulation (n = 4) (right). Values are the mean ± SEM.∗Significant difference between treatments
(P < 0.05).
10−5 M ACh for 5 min for the determination of tension
development and NM myosin II filament formation.
Treatment with blebbistatin inhibited force development
(Fig. 5A), although it had no effect on NM myosin II
filament formation as assessed by the Triton solubility
assay (Fig. 5B). Blebbistatin also did not inhibit the
phosphorylation of NMmyosin on Ser1943 in response to
ACh (Fig. 5C).Wealso assessed the effect of blebbistatin on
NM myosin II filament formation using the PLA assay to
assess interactions betweenNMmyosin IIA andNMmyo-
sin IIB in freshly dissociated tracheal muscle cells. Cells
were treated with 2 μM blebbistatin prior to stimulation
with 5 min 10−5 M ACh (Fig. 5D). Blebbistatin had no
effect on the interaction of NM myosin IIA and IIB,
suggesting that it did not inhibit NM myosin II filament
formation in response to ACh. Thus, the results obtained
using blebbistatin are consistent with the interpretation
that NM myosin filament formation is a distinct step
that occurs independently of actin-activated cross-bridge
cycling by NMmyosin II.
We next evaluated the effect of blebbistatin on the
assembly and activation of adhesome complexes in
response to ACh. PLA was used to assess the effect of
blebbistatin on the formation of vinculin/talin complexes
in freshly dissociated cells (Fig. 5E). Blebbistatin inhibited
the formationof vinculin/talin complexes at the cell cortex.
Blebbistatin also inhibited the tyrosine phosphorylation of
both vinculin and paxillin in tissues stimulated with ACh
for 5 min (Fig. 5F).
The results obtained indicate thatNMmyosin II ATPase
activity and cross-bridge cycling are required for tension
development in smooth muscle, and that the inhibition
of NM myosin II cross-bridge cycling inhibits tension
development by preventing the assembly and activation
of membrane adhesome complexes. By contrast, both the
Triton solubility assay and the PLA assays for NMmyosin
IIA and IIB interaction indicate that blebbistatin does not
inhibit NM myosin II filament formation in response to
stimulation with ACh.
RhoA GTPase regulates NM myosin RLC
phosphorylation during the contractile stimulation
of smooth muscle tissues
The role of myosin RLC phosphorylation in the
activation of actin-activated myosin ATPase activity is
well established for both SM and NM myosin II. We used
two-dimensional gel electrophoresis to evaluate the effect
of contractile stimulation on the phosphorylation of NM
myosin II RLC in tracheal smooth muscle tissues. NM
and SM myosin RLC isoforms cannot be distinguished
immunologically because their sequences differ only
slightly (Gaylinn et al. 1989; Yuen et al. 2009).
NM and SM myosin RLCs extracted from ACh-
stimulated and unstimulated smooth muscle tissues were
separated according to differences in isoelectric focusing.
At the 20 kDa molecular weight, three distinct spots
were observed in extracts from unstimulated tissues and
four distinct spots in extracts from ACh stimulated
tissues (Fig. 6A). Mass spectrometry was performed
on proteins extracted from these gels to confirm the
sequences of these spots. The two less acidic spots
(Spots 1 and 2) consisted of unphosphorylated SM myo-
sin RLC (Spot 1) and Ser19-phosphorylated SM myo-
sin RLC (Spot 2). The two more acidic spots (Spots 3
and 4) contained unphosphorylated NM myosin RLC
(Spot 3) and Ser19-phosphorylated NM myosin RLCs
(Spot 4). However, di-phosphorylated (Thr18 and Ser19)
SM myosin RLC was present in extracts from stimulated
smooth muscle tissues and was found to co-migrate with
unphosphorylated NMmyosin RLC (Spot 3).
Figure 6A illustrates immunoblots of NM and SM
RLCs from extracts of unstimulated and ACh-stimulated
C© 2017 The Authors. The Journal of Physiology C© 2017 The Physiological Society
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Figure 5. The NM myosin II cross-bridge cycling inhibitor, blebbistatin suppresses ACh-induced tension
development and the assembly and activation of membrane adhesome complexes, although it does
not inhibit NM myosin II assembly
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A, blebbistatin significantly inhibited force generation in response to 10−5 M ACh stimulation in tracheal smooth
muscle (n = 8). B, immunoblot of cytosolic (soluble, S) and cytoskeletal (pellet, P) fractions from extracts of
tracheal smooth muscle tissues treated with 10 µM blebbistatin or untreated (Control) and stimulated with ACh
or unstimulated (US). Blebbistatin did not significantly affect the ACh-induced increase in ratio of NM myosin II
in the cytoskeletal (P) vs. soluble (S) fractions in response to 5 min of stimulation with 10−5 M ACh (n = 7). C,
increase in NM myosin II Ser1943 phosphorylation in tracheal muscle tissues in response to 5 min of stimulation
with 10−5 M. ACh was not significantly affected by blebbistatin (n = 12). D, blebbistatin had no significant effect
on the increase in the number of NM myosin IIA and IIB complexes at the cell membrane in response to ACh
(Control: US cells, n = 18; ACh stimulated cells, n = 28. Blebbistatin treated cells: US, n = 20; ACh, n = 29).
Images show in situ PLA fluorescence (top) and PLA fluorescence merged with phase contrast (bottom) from freshly
dissociated smooth muscle cells US or stimulated with ACh. PLA spots show interactions between NM myosin
IIA and NM myosin IIB in freshly dissociated cells (left). E, PLA spots show interactions between talin and vinculin
in freshly dissociated cells (left). ACh stimulation resulted in a significant increase in the number of talin-vinculin
complexes at the cell membrane in control cells (US, n = 24; ACh, n = 24). By contrast, few spots were observed
in blebbistatin treated cells (US, n = 24; ACh, n = 25). Very few spots are observed in the unstimulated control
cells and blebbistatin treated cells. F, representative immunoblot from extracts of two control muscle tissues and
two blebbistatin treated tissues stimulated with ACh or not stimulated (US) (left). The increase in vinculin Tyr1065
phosphorylation and paxillin Tyr118 phosphorylation in response to 10−5 M ACh was significantly inhibited in
tissues treated with blebbistatin (n = 7). Values are the mean ± SEM.∗Significant difference between treatments
(P < 0.05). ns, not significantly different.
smooth muscle tissues. Membranes were immunoblotted
using antibody that reacts with both NM and SM RLC
and with antibody against Ser19 RLC and then visualized
by dual immunofluorescence. Immunoblots confirmed
the presence of Ser19 phosphorylated RLC in Spot 2
from unstimulated samples and in Spots 2, 3 and 4
from ACh-stimulated samples. The proportion of NM
and SM RLCs was quantified from immunoblots from
unstimulated smooth muscle tissues by comparing the
proportion of RLCs and Spots 1 and 2 vs. Spots 3
and 4. NM RLCs represented 18.7 ± 2.2% of the total
RLCs present in the tracheal smooth muscle tissues
(Fig. 6B).
The phosphorylation of SMmyosin RLCwas quantified
basedon thedensity of unphosphorylated SMmyosinRLC
(Spot 1) relative to the proportion of SM myosin RLC to
total RLC (Fig. 6C). The effect of ACh stimulation on
the phosphorylation of NM myosin RLC was quantified
based on the density of the phosphorylated NM myo-
sin RLC (Spot 4) relative to the proportional NM myosin
RLC to total RLC (Fig. 6C). BothNMand SMmyosin RLC
exhibited low levels of phosphorylation in resting tissues.
The phosphorylation of both isoforms increased by a
similar proportion in response to stimulation of airway
smooth muscle tissues with 10−5 M ACh for 5 min. These
results demonstrate that stimulation with ACh activates
both SM and NM myosin II similarly in airway smooth
muscle.
RhoA inhibition suppresses actin polymerization and
tension development in response to ACh, although it has
only a small effect on total myosin RLC phosphorylation
as assessed by one-dimensional urea gel electrophoresis
(Zhang et al. 2010). However, we previously showed
that RhoA activation is critical for the recruitment of
proteins to membrane adhesomes and the activation
of adhesome signalling complexes during contractile
stimulation of airway smooth muscle tissues (Zhang et al.
2012). We evaluated the role of RhoA in NM myosin
RLC phosphorylation by expressing the RhoA inactive
mutant, RhoA T19N, in tracheal smooth muscle tissues
to inhibit endogenous RhoA activation (Zhang et al.
2010, 2012) (Fig. 6D). The inactivation of RhoA almost
completely suppressed ACh-stimulated NM myosin II
RLC phosphorylation, although it did not significantly
affect SM myosin RLC phosphorylation (Fig. 6E). These
observations suggest that RhoA selectively regulates the
activation of NM myosin II but not the SM myosin RLC
isoforms.
The phosphorylation NM myosin RLC regulates NM
myosin II filament assembly during the contractile
stimulation of smooth muscle tissues
We assessed the role of RhoA in the regulation of NM
myosin II filament assembly in airway smooth muscle.
The expression of RhoA T19N in tracheal smooth muscle
tissues inhibited the increase in NM myosin II into the
cytoskeletal fraction in ACh stimulated tissues, which is
consistent with the inhibition of NM myosin II filament
assembly (Fig. 7A). In situ PLA was also performed on
freshly dissociated tracheal smoothmuscle cells to evaluate
the role of RhoA on NMmyosin II filament formation. In
smooth muscle cells dissociated from tissues expressing
the RhoA T19N mutant, ACh did not induce interactions
between NMmyosin IIA and IIB isoforms, whereas many
interactions were detected in ACh-stimulated cells from
Sham-treated tissues (Fig. 7B).
We evaluated the effect of RhoA inhibition on
ACh-induced NM myosin II heavy chain Ser1943
phosphorylation in tracheal smooth muscle tissues by
expressing the RhoA T19N mutant in tracheal smooth
muscle tissues (Fig. 7C). RhoA inhibition prevented
the increase in NM myosin II heavy chain Ser1943
C© 2017 The Authors. The Journal of Physiology C© 2017 The Physiological Society
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phosphorylation in response to ACh stimulation. The
inhibition of tension development by RhoA T19N was
similar to that caused by expression of the NM myo-
sin S1943A mutant (Figs 3D and 7C). The results
are consistent with the possibility that activated RhoA
mediates NM myosin II RLC phosphorylation and also
that NM RLC phosphorylation regulates the conversion
of NMmyosin II to an assembly-competent conformation
that can then undergo Ser1943 phosphorylation on its
heavy chain, thereby promoting filament formation. Thus,
the results suggest that Rho-mediated NM myosin RLC
phosphorylation is a necessary prerequisite for NM myo-
sin II filament assembly in airway smooth muscle tissues.
In addition, the results indicate that RhoA regulates air-
way smooth muscle contraction by regulating NM myo-
sin assembly and activation rather than by regulating SM
myosin activation.
Discussion
The present study demonstrates that NM myosin II plays
a critical role in the regulation of airway smooth muscle
contraction. We find that the function of NM myosin II
in airway smooth muscle is quite different from that of
SMmyosin II: smooth muscle myosin plays a well-known
role in generating cell shortening via actomyosin filament
sliding, whereas NM myosin mediates the assembly
of membrane adhesome complexes that connect actin
filaments to the extracellular matrix for the transmission
of tension to the outside of the cell (Fig. 8). The
results suggest that the contractile stimulation of airway
smooth muscle regulates the assembly of NM myosin II
into filaments, and that NM myosin filament assembly
is required for active contractile tension generation in
smooth muscle tissues. Furthermore, the results suggest
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Figure 7. RhoA GTPase regulates NM myosin II assembly, NM myosin heavy chain Ser1943
phosphorylation and tension development during ACh stimulation
A, left: immunoblot of cytoplasmic (soluble, S) and cytoskeletal (pellet, P) fractions of tracheal smooth muscle
extracts from tissues treated with RhoA T19N or Sham-treated, and stimulated with ACh or unstimulated (US). The
ratio of NM myosin II in the cytoskeletal (P) vs. soluble (S) fractions increased in response to 5 min of stimulation
with 10−5 M ACh in Sham-treated tissues, although it was significantly inhibited by the expression of RhoA T19N
in 10−5 M ACh-stimulated tissues (n = 6). B, images of in situ PLA fluorescence (top) and PLA fluorescence merged
with phase contrast (bottom) from freshly dissociated smooth muscle cells US or stimulated with ACh. PLA spots
show interactions between NM myosin IIA and NM myosin IIB in cells dissociated from Sham-treated tissues (left).
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ACh stimulation of Sham-treated tissues resulted in a significant increase in the number of NM myosin IIA and IIB
complexes at the cell membrane (n = 27, US; n = 30, ACh). By contrast, few NM myosin IIA and IIB complexes
were observed in cells from tissues treated with the RhoA T19N (US, n = 26; ACh, n = 20). Very few NM myosin
IIA and IIB complexes are observed in the unstimulated cells. C, increase in NM myosin II Ser1943 phosphorylation
in response to 5 min of stimulation with 10−5 M ACh was significantly inhibited in tissues expressing RhoA T19N
compared to Sham-treated tissues (n = 8). Contractile force in response to ACh is shown for tissues before and
after they were transfected with plasmids encoding RhoA T19N or no plasmids (Sham-treated) (left). Expression
of RhoA T19N significantly inhibited force generation in response to 10−5 M ACh stimulation in tracheal smooth
muscle. All force measurements normalized to Sham response. Values are the mean ± SEM. ∗Significant difference
between treatments (P < 0.05).
that the contractile activation of tracheal smooth muscle
regulates NMmyosin filament assembly by regulating the
RhoA-dependent phosphorylation of the NM myosin II
RLC, and by regulating the phosphorylation of the NM
myosin II heavy chain on Ser1943 (Fig. 8). Contractile
stimulation activates proteinswithin adhesome complexes
that mediate pathways catalysing cortical actin poly-
merization, which is also required for tension generation
in smooth muscle. We conclude that NM myosin II plays
an essential role in the physiological responses of air-
way smooth muscle tissues to extracellular contractile
stimulation that is completely distinct from that of SM
myosin (Fig. 8).
The assembly of NM myosin II in response to
extracellular stimulation has never been demonstrated in
smoothmuscle tissues, in which the predominant isoform
of myosin II is SMmyosin. We used several approaches to
evaluate the assembly of NM myosin filaments during
airway smooth muscle contraction. One method was to
quantify the proportion of NM myosin II in the cyto-
skeletal vs. Triton-soluble fractions of smooth muscle
tissue extracts, amethodpreviously used todocumentNM
myosin filament assembly during adhesion andmigration
in several non-muscle cancer cell lines (Dulyaninova et al.
2005, 2007; Breckenridge et al. 2009). The proportion of
both isoforms of NM myosin II was higher in the cyto-
skeletal fraction of tissue extracts after stimulation with
ACh than in unstimulated muscles, which is consistent
with an increase in the formation of NM myosin II
filaments that can interact with F-actin and cytoskeletal
proteins. Because the10Smyosin IImonomer cannot form
filaments or bind to actin (Wendt et al. 1999; Jung et al.
2008), it should remain in the soluble fraction, whereas
the NM myosin found in the cytoskeletal fraction should
be filamentous.
We further assessed NM myosin II filament formation
by using in situ PLA to probe for interactions between
NM myosin IIA and IIB (Fig. 1). NM myosin II can form
mixed heterotypic NM myosin filaments in living cells
(Beach et al. 2014; Beach & Hammer, 2015). In situ PLA
detects protein associations that are less than 40 nm, a
proximity that is usually indicative of binding between
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the target proteins (Soderberg et al. 2006, 2008). Thus,
the PLA signals probably represent binding interactions
between NM myosin II monomers. We detected very few
interactions between NM myosin IIA and IIB isoforms
in resting smooth muscle cells, although we observed
a dramatic increase in NM myosin IIA and IIB inter-
actions after contractile stimulation. These observations
are consistent with the interpretation that NM myosin II
exists inmonomeric form in restingunstimulatedmuscles,
possibly in a pool of assembly-incompetent monomers
(Milton et al. 2011) and also that contractile stimulation
triggers the polymerization of NM myosin II mono-
mers into filaments. In combination, our results provide
strong evidence that contractile stimulation regulates the
assembly of a pool of NMmyosin II into filaments.
The effects of treating the tissues with the NM
myosin II cross-bridge cycling inhibitor, blebbistatin,
provide further evidence for a role for NM myosin II
in the regulation of airway SM contraction, and provide
additional evidence that NMmyosin filament assembly is
triggered by contractile stimulation (Fig. 5). Blebbistatin
binds to the myosin-ADP-Pi complex with high affinity
and interferes with the phosphate release process, thus
blockingmyosin in an actin-detached state and preventing
actomyosin cross-linking (Kovacs et al. 2004). It acts
selectively on the NM myosin II by inhibiting the myo-
sin ATPase, but it has no effect on myosin light chain
kinase or smooth muscle myosin II (Straight et al. 2003;
Kovacs et al. 2004). We found that blebbistatin had no
effect on ACh-induced NMmyosin filament formation as
assessed by either the Triton solubility assay or PLA for
NM myosin IIA and IIB interactions (Fig. 5). However,
blebbistatin inhibited force development and the assembly
and activation of adhesome complexes in response toACh.
Because blebbistatin prevents NMmyosin II from binding
to actin filaments, our results are consistent with the inter-
pretation that the Triton solubility assay assessesNMmyo-
sin II filament formation rather than the interaction of
NM myosin II with actin filaments or the formation of
cytoskeletal protein complexes containing NM myosin II.
Our observations of few interactions between NMmyosin
IIA and IIB being observed in resting smooth muscle cells
and blebbistatin not inhibiting interactions between NM
myosin IIA and IIB in stimulated tissues further support
the idea that NM myosin II forms filaments after ACh
stimulation. In summary, our studies with blebbistatin
provide additional evidence that NM myosin II filament
formation and NM myosin cross-bridge cycling are both
necessary for the assembly and activation of adhesome
complexes during the contractile stimulation of airway
smoothmuscle, and also that adhesome complex assembly
is necessary for tension development.
The contractile stimulation of airway smooth muscle
tissues with ACh resulted in the phosphorylation of NM
myosin on its non-helical tail domain on Ser1943. We
inhibited the Ser1943 phosphorylation of endogenous
NM myosin during contraction of the smooth muscle
tissues by expressing the non-phosphorylatable NMmyo-
sin IIAmutant, NMmyosin S1943A. This inhibited airway
smooth muscle contraction and prevented NM myosin II
filament assembly, as assessed by both the Triton solubility
assay and the PLA assay for interaction between NMmyo-
sin IIA and IIB. Blebbistatin inhibited adhesome complex
assembly and the activation of adhesome proteins,
presumably by inhibiting NM myosin II cross-bridge
cycling; however, it had no effect on NM myosin II
Ser1943 phosphorylation or on filament assembly. These
results are consistent with a role for NM myosin heavy
chain phosphorylation at Ser1943 in promoting filament
formation during contractile stimulation and support
the conclusion that NM myosin II filament assembly is
necessary for tension generation (Figs 2 and 3).
The NM myosin heavy chain has been reported to
undergo phosphorylation at the Ser1943 site in several
carcinoma cell lines in vivo (Dulyaninova et al. 2007;
Dulyaninova & Bresnick, 2013; Heissler & Sellers, 2016).
The in vivo expression of NM myosin S1943A in these
cells reduced cell migration and lamellipod extension
(Dulyaninova et al. 2007), which is consistent with our
observations of reduced contractility in airway smooth
muscle tissues. By contrast, in molecular studies using
NM myosin rod C-terminal tail fragments in vitro, the
phosphorylation of NM myosin IIA at Ser1943 resulted
in the disassembly of existing NM myosin II filaments
or inhibited the formation of filaments by NM myosin
II monomers (Murakami et al. 1995, 1998; Dulyaninova
et al. 2005). The apparent differences in the effect of NM
myosin II heavy chain phosphorylation on NM myo-
sin filament assembly in the in vitro studies and in our
in vivo studies may be a result of the exclusive use of
NM myosin II tail fragments in the in vitro studies,
which might not be reliable surrogates for full-length NM
myosin II. Furthermore, the effect of phosphorylation
on the assembly of the NM myosin IIA isoform was
shown to be highly dependent on the stoichiometric
level of phosphate incorporation into the heavy chain
(Dulyaninova et al. 2005), which could differ in vivo
and in vitro. Other aspects of in vivo conditions, such as
the presence of myosin-binding proteins and other heavy
chain phosphorylation events, might also alter the effect
of Ser1943 phosphorylation on the molecular function of
NMmyosin II in vivo. It is also possible that NMmyosin II
filament assembly in living cells requires the disassembly
of existing NM myosin II filaments to generate a pool of
NM myosin II monomers that are reincorporated into
de novo NM myosin II filaments. However, this
explanation does not explain the marked increase in NM
myosin IIA and IIB isoform interactions that occurred
in response to ACh. The molecular function of NM
myosin heavy chain Ser1943 phosphorylation on NM
C© 2017 The Authors. The Journal of Physiology C© 2017 The Physiological Society
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myosin II filament assembly has not been assessed pre-
viously in living cells.
We demonstrated that RhoA selectively regulates the
phosphorylation of NM myosin RLC: RhoA inhibition
had no significant effect on the RLC phosphorylation of
SMmyosin induced by ACh, although it caused a marked
inhibition of the NM myosin RLC phosphorylation
(Fig. 6). Phosphorylation of the RLC is widely recognized
as a key step in the regulation of actin-activated ATPase
activity for both NM and SM myosin II. The results
of the present study show that NM myosin II can be
activated separately from SM myosin and the contra-
ctile apparatus and regulates the assembly of adhesomes
that mediate signalling pathways critical for smooth
muscle cell processes elicited by non-contractile stimuli,
as well as contractile stimuli (Desai et al. 2011; Wu et al.
2016). Thus, the activation of NM myosin II may be
fundamental to the phenotypic and synthetic responses
of the cell to extracellular stimuli that that do not activate
contraction.
Myosin RLC chain phosphorylation is required for
the inactive folded assembly-incompetent conformer
of monomeric myosin II to assume an open
assembly-competent conformation in vitro (Craig et al.
1983; Smith et al. 1983; Trybus & Lowey, 1984); however,
there is no evidence regarding phosphorylation of the
RLC being important for regulating either NM or SM
myosin filament assembly in vivo. We found that NM
myosin II filament assembly was inhibited in smooth
muscle cells in whichNMmyosin II RLC phosphorylation
was prevented by RhoA inactivation. The results are
consistent with the possibility that NM myosin II RLC
phosphorylation regulates the conversion of NM myo-
sin monomers to an assembly-competent conformation
in smooth muscle. However, because we cannot directly
measure the conformation of NM myosin monomers in
the cells, it is possible that RhoA regulates NM myo-
sin II assembly in airway smooth muscle through an
alternative mechanism. Regardless of the mechanism, the
ability to selectively inactivate NM myosin II assembly
in airway smooth muscle by inactivating RhoA provides
further evidence for the distinct cellular function of
NMmyosin during contraction. NMmyosin inactivation
prevents adhesome assembly, suppresses cytoskeletal
signalling, and inhibits actin polymerization and tension
development without affecting SM RLC phosphorylation
and SM myosin activation.
The expression of NMmyosin II in smooth muscle has
long been recognized; however, its physiological function
in muscle tissues has never been established (Eddinger &
Meer, 2007). In non-muscle cells, the functions of NM
myosin II have been studied extensively and its roles
in adhesion and cell crawling are widely documented
(Vicente-Manzanares et al. 2009). By contrast, there
are few studies of the function of NM myosin II in
smooth muscle. Studies investigating the physiological
properties of bladder smooth muscle tissues from SM
myosin knockout mice demonstrated that the contra-
ctility of bladder strips from these mice was markedly
diminished (Morano et al. 2000; Lofgren et al. 2003);
however, the tissues were still capable of generating
slow contractions that produced very low levels of tonic
force. Although these studies suggested a possible role
for NM myosin II in smooth muscle contraction, they
were not definitive because it is impossible to rule out
compensatory changes in the expression or function of
other proteins in tissues from these knockout animals.
Yuen et al. (2009) demonstrated that the activation of
NM myosin II is regulated by Ca2+-calmodulin activated
myosin light chain kinase in mouse aortic tissues during
smooth muscle contraction. They also found that force
maintenance was slightly reduced in the aortas from NM
myosin IIB knockoutmice and suggested that NMmyosin
IIB plays a role in force maintenance.
The results of the present study demonstrate that the
function of NMmyosin II is critical to force development
in airway smoothmuscle: when the assembly or activation
ofNMmyosin II is inhibited, force development is reduced
by 60%. Furthermore, we show that contractile stimuli can
regulate the activation of NMmyosin II by regulating NM
myosin heavy chain phosphorylation, as well as NMmyo-
sin II regulatory light chain phosphorylation. These results
suggest a central role for NM myosin II in airway smooth
muscle contraction that is probably broadly relevant to
other smooth muscle tissue types.
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